Liposomal formulations for lung cancer treatment in the last two decades: a systematic review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00432-022-04079-x.pdf
Reference38 articles.
1. Boulikas T (2009) Clinical overview on lipoplatin: a successful liposomal formulation of cisplatin. Expert Opin Investig Drugs 18:1197–1218
2. Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: an updated review. Pharmaceutics 9:12
3. Butts C, Maksymiuk A, Goss G, Soulières D, Marshall E et al (2011) Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial. J Cancer Res Clin Oncol 137:1337–1342
4. Butts C, Murray N, Maksymiuk A, Goss G, Marshall E et al (2005) Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. J Clin Oncol 23:6674–6681
5. Butts C, Murray RN, Smith CJ, Ellis PM, Jasas K et al (2010) A multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancer. Clin Lung Cancer 11:391–395
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predictive Modeling of Breast Cancer Outcomes Using Supervised Machine Learning Algorithms;International Journal of Scientific Research in Computer Science, Engineering and Information Technology;2024-08-15
2. Empowering lung cancer treatment: Harnessing the potential of natural phytoconstituent‐loaded nanoparticles;Phytotherapy Research;2024-05-28
3. Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review;Vaccines;2022-09-21
4. Regulatory safety evaluation of nanomedical products: key issues to refine;Drug Delivery and Translational Research;2022-07-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3